Posts From Andrew Wright


Andrew Wright

Prior to founding in 2014, Andrew worked as a proprietary trader, then as a market maker. As a market maker, he traded options in over 100 stocks, he then began trading currency pairs in 2013. Andrew still actively trades both, and prides himself on educating and informing traders on the benefits of both Binary Options and Forex.

Thai Central Bank Slashes Interest Rate To Spur Growth

  The greenback rallied against Thai Baht yesterday after the central bank of Thailand trimmed its benchmark interest rate in a surprising move, pointing to weaker-than-anticipated outlook, in part due to the Wuhan coronavirus epidemic. In the past 24 hours,

Read More

Coke Posts Q4 Beat on a Rise in Demand for Namesake Brand

  Coca-Cola Co. (NYSE: KO) posted a 16% increase in fiscal 2019 fourth-quarter earnings, led by robust sales growth of concentrate and price/product mix growth. Organic revenues also increased by 7% on a y-o-y basis. The company also issued FY

Read More

Swiss Franc Strengthens on Coronavirus Risk-Off Mode

  The euro dollar continues to decline against the Swiss franc after Germany’s Ifo institute reported an unexpected decline in the business sentiment index. The downtrend was also aided by the market’s switch over to risk-off mode due to increasing

Read More

BoA Estimates Boeing 737 MAX Crisis Could Hit $20bln.

  The shares Boeing (NYSE: BA) came under selling pressure after Ron Epstein, aerospace analyst at Bank of America Merrill Lynch, estimated that the cost of grounding the 737 MAX, its best-selling aircraft, could reach $20 billion. The stock closed

Read More

Olive Oil Producer CHO to Fight Fraud Using IBM Blockchain

  The cryptocurrency market remains slightly bullish, with Bitcoin (BTC) trading above the crucial level of $8,300. At the time of writing this article, the cryptocurrency with a market dominance rate of 66.8% is trading at $8,632, representing a small

Read More

Eli Lilly to Buy Skin Treatment Firm Dermira for $1.1bln

  Eli Lilly and Co (LLY: NYSE) is acquiring biopharmaceutical company Dermira (NASDAQ: DERM) in a deal valued at $1.10 billion. The sale will give Eli Lilly access to late-phase competitor Regeneron and Sanofi’s blockbuster drug Dupixent, an atopic dermatitis

Read More

Takasbank Unveils Blockchain-Based Digital Gold Transfer

  The cryptocurrency market remains slightly bullish with Bitcoin (BTC) trying to move towards a $10,000 mark. At the time of writing this article,  Bitcoin was trading at $7,905, representing a gain of 4.8% in the past 24 hours. Likewise,

Read More

PBoC Boosts Liquidity via Cut in 14-Day Reverse Repo Rate

  The US dollar rose 0.08% against the Chinese yuan to trade at 7.0023 on Wednesday after the People’s Bank of China (PBoC) slashed its 14-day reverse repurchase rate, after slashing the short-term 7-day repo rate a month ago. China’s

Read More

UBS Analyst Upwardly Revises GE’s Rating to “Buy”

  The shares of General Electric Co (NYSE: GE) surged $0.47 or 4.28% to close at $11.44 after Markus Mittermaier, a new analyst at UBS, began his coverage of the industrial behemoth with a “buy” rating. Earlier, the company carried

Read More

Eurozone Investor Confidence Rises, Recession Fear Fades

  The euro dollar traded in a narrow range against the yen despite an unexpected increase in German exports in October and strong rise in Sentix business confidence in December. The upbeat Q3 GDP growth data from Japan enabled the

Read More